The ROE as of September 2024 (TTM) for Acurx Pharmaceuticals, Inc. (ACXP) is -371.20%

According to Acurx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -371.20%. This represents a change of 288.68% compared to the average of -95.50% of the last 4 quarters.

Acurx Pharmaceuticals, Inc. (ACXP) Historical ROE (quarterly & annually)

How has ACXP ROE performed in the past?

The mean historical ROE of Acurx Pharmaceuticals, Inc. over the last ten years is -294.72%. The current -371.20% ROE has changed 25.95% with respect to the historical average. Over the past ten years (40 quarters), ACXP's ROE was at its highest in in the December 2022 quarter at 27.77%. The ROE was at its lowest in in the March 2020 quarter at -156.02%.

Acurx Pharmaceuticals, Inc. (ACXP) ROE by Quarter and Year

Discovering the peaks and valleys of Acurx Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acurx Pharmaceuticals, Inc. (ACXP) Average ROE

How has ACXP ROE performed in the past?

The current ROE of Acurx Pharmaceuticals, Inc. (ACXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Acurx Pharmaceuticals, Inc. (ACXP) ROE vs. Peers

How is ACXP’s ROE compared to its peers?

Acurx Pharmaceuticals, Inc.’s ROE is greater than Aerovate Therapeutics, Inc. (-83.65%), greater than Adagene Inc. (-63.48%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Rezolute, Inc. (-60.90%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Silo Pharma, Inc. (-56.41%), greater than Protagenic Therapeutics, Inc. (-238.37%), greater than Lumos Pharma, Inc. (-157.99%), greater than Candel Therapeutics, Inc. (-629.29%), greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Monopar Therapeutics Inc. (-110.60%), greater than Enochian Biosciences, Inc. (-70.62%),

Build a custom stock screener for Acurx Pharmaceuticals, Inc. (ACXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acurx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acurx Pharmaceuticals, Inc. (ACXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acurx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.